Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IYH vs. FTXH: which is better?

Bottom line

IYH vs FTXH: the short answer

IYH (iShares U.S. Healthcare ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 50% by weight.

But IYH is far broader, holding 103 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.

IYH is cheaper at 0.37% vs 0.6% — a difference of $23 a year per $10,000 invested.

Over five years, IYH returned +7.0% a year vs +6.5% for FTXH.

Updated Nov 19, 2026

IYH vs FTXH side by side

IYHFTXH
TypeETFETF
Fund familyiSharesFirst Trust
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.37%0.6%
Annual cost per $10k$37$60
10-yr cost on $10k (prospectus)$468—
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+13.1%+24.0%
5-yr return (annualized)+7.0%+6.5%
10-yr return (annualized)+9.4%—
Best quarter+15.3%+18.3%
Worst quarter−12.7%−17.4%
Net assets (fund)$3.6B$36.2M
Number of holdings10351
Portfolio turnover3%35%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIYHFTXHDifference
2025+13.1%+24.0%−10.9%
2024+3.1%+3.0%+0.1%
2023+2.1%−1.4%+3.5%
2022−4.4%+2.5%−6.9%
2021+23.4%+6.1%+17.3%
2020+15.5%+10.9%+4.6%
2019+20.8%+22.4%−1.5%
2018+5.9%−8.4%+14.2%
2017+22.3%+18.8%+3.5%

Source: Fund prospectus bar charts

Holdings overlap

10 of IYH's top 25 holdings also appear in FTXH's top 25.

Shared top holdings
HoldingIYHFTXH
Eli Lilly And Company15.11%7.77%
Johnson & Johnson10.17%6.96%
Abbvie Inc.7.32%7.39%
Merck & Co., Inc.5.31%7.07%
Amgen Inc.3.42%3.18%
Gilead Sciences, Inc.2.66%2.89%
Pfizer Inc.2.35%2.97%
Bristol-myers Squibb Company2.20%6.29%
Vertex Pharmaceuticals Incorporated2.00%3.41%
Regeneron Pharmaceuticals, Inc.1.27%2.72%

Source: SEC Form N-PORT

IYH top 10

  1. Eli Lilly And Company — 15.11%
  2. Johnson & Johnson — 10.17%
  3. Abbvie Inc. — 7.32%
  4. Unitedhealth Group Incorporated — 6.16%
  5. Merck & Co., Inc. — 5.31%
  6. Thermo Fisher Scientific Incorporated — 3.52%
  7. Amgen Inc. — 3.42%
  8. Abbott Laboratories — 3.02%
  9. Gilead Sciences, Inc. — 2.66%
  10. Pfizer Inc. — 2.35%

FTXH top 10

  1. Eli Lilly & Company — 7.77%
  2. Abbvie Inc — 7.39%
  3. Merck & Company Inc — 7.07%
  4. Johnson & Johnson — 6.96%
  5. Bristol-myers Squibb Company — 6.29%
  6. Biogen Inc — 3.84%
  7. Viatris Inc — 3.62%
  8. Cardinal Health Inc — 3.53%
  9. Vertex Pharmaceuticals Inc — 3.41%
  10. Amgen Inc — 3.18%

FAQ

What is the difference between IYH and FTXH?
IYH (iShares U.S. Healthcare ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 50% by weight. But IYH is far broader, holding 103 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.
Which is cheaper, IYH or FTXH?
IYH has the lower expense ratio (0.37%).
Should I own both IYH and FTXH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.